Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply
PharmaEssentia Japan K.K.
PharmaEssentia Japan K.K.
Incyte Corporation
Hoffmann-La Roche
Hoffmann-La Roche
CTI BioPharma
Novartis
CTI BioPharma
Novartis
Italfarmaco
Italfarmaco
Italfarmaco
Novartis
Incyte Corporation
Incyte Corporation
INSYS Therapeutics Inc